Literature DB >> 20083550

Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection.

Nuria Fernández-Hidalgo1, Joan Gavaldà, Benito Almirante, María-Teresa Martín, Pedro López Onrubia, Xavier Gomis, Albert Pahissa.   

Abstract

BACKGROUND: The effectiveness of linezolid, vancomycin, ciprofloxacin and gentamicin for treating experimental Staphylococcus aureus catheter-related infection by the antibiotic-lock technique was assessed.
METHODS: Two methicillin-susceptible (MSSA) ATCC strains and two methicillin-resistant (MRSA) clinical strains were used. New Zealand white rabbits were surgically implanted with a silicone intravenous catheter. Infection was induced by filling and locking the catheter with 0.3 mL of broth culture containing S. aureus, with turbidity equivalent to that of a 0.5 McFarland standard. Eighteen hours later the antibiotic-lock technique was started and continued for 24 h. Treatment groups were: control without treatment; 2000 mg/L linezolid; 2000 mg/L vancomycin; 2000 mg/L ciprofloxacin; and 40,000 mg/L gentamicin.
RESULTS: Linezolid and vancomycin showed equivalent activity, achieving significant reductions in log(10) cfu recovered from catheter tips in one MSSA strain (>1.12) and one MRSA strain (>0.77) as compared with controls (P < 0.05). Ciprofloxacin achieved significant log(10) cfu reductions in MSSA strains relative to controls (>2.51, P < 0.01). In one MSSA strain, ciprofloxacin showed a larger reduction in log(10) cfu than linezolid or vancomycin (P < 0.01). Gentamicin was the only antibiotic achieving negative catheter tip cultures (up to 87.5% in MSSA and up to 40% in MRSA, P < 0.01), and showed the greatest log(10) cfu reduction compared with controls (>4.25 in MSSA and >2.93 in MRSA, P < 0.05) and significant differences relative to the remaining treatment groups (P < 0.05 in both MSSA and MRSA).
CONCLUSIONS: Gentamicin showed the highest activity against both MSSA and MRSA biofilms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083550     DOI: 10.1093/jac/dkp499

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Study of in vivo catheter biofilm infections using pediatric central venous catheter implanted in rat.

Authors:  Ashwini Chauhan; Jean-Marc Ghigo; Christophe Beloin
Journal:  Nat Protoc       Date:  2016-02-18       Impact factor: 13.491

2.  Experimental model of biofilm implant-related osteomyelitis to test combination biomaterials using biofilms as initial inocula.

Authors:  Dustin L Williams; Bryan S Haymond; Kassie L Woodbury; J Peter Beck; David E Moore; R Tyler Epperson; Roy D Bloebaum
Journal:  J Biomed Mater Res A       Date:  2012-04-10       Impact factor: 4.396

Review 3.  Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review.

Authors:  Matteo Vassallo; Brigitte Dunais; Pierre-Marie Roger
Journal:  Infection       Date:  2015-02-06       Impact factor: 3.553

4.  A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections.

Authors:  Ashwini Chauhan; David Lebeaux; Benoit Decante; Irene Kriegel; Marie-Christine Escande; Jean-Marc Ghigo; Christophe Beloin
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

Review 5.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Authors:  David Lebeaux; Ashwini Chauhan; Olaya Rendueles; Christophe Beloin
Journal:  Pathogens       Date:  2013-05-13

Review 6.  Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition.

Authors:  Dane Christina Daoud; Geert Wanten; Francisca Joly
Journal:  Nutrients       Date:  2020-02-10       Impact factor: 5.717

7.  Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants.

Authors:  Hong Liang; Lian Zhang; Xiaoping Guo; Li Sun
Journal:  BMC Pediatr       Date:  2021-01-04       Impact factor: 2.125

8.  Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.

Authors:  Francesca Sivori; Ilaria Cavallo; Daniela Kovacs; Maria Guembe; Isabella Sperduti; Mauro Truglio; Martina Pasqua; Grazia Prignano; Arianna Mastrofrancesco; Luigi Toma; Fulvia Pimpinelli; Aldo Morrone; Fabrizio Ensoli; Enea Gino Di Domenico
Journal:  Microbiol Spectr       Date:  2022-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.